Topical Remedy Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $600K
Latest Deal Amount
  • Investors
  • 2

Topical Remedy General Information

Description

Developer of novel topical drugs designed to cure various skin diseases. The company's drugs are formulated for herpes labialis and is suitable for the OTC market, enabling patients to get effective remedial treatments.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Primary Office
  • 5285 Meadows Road
  • Suite 161
  • Lake Oswego, OR 97035
  • United States
+1 (503) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Topical Remedy Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 12-Jun-2019 $600K 00.000 Completed Clinical Trials - Phase 2
2. Later Stage VC (Series A) 26-Jun-2017 00000 00.000 Completed Clinical Trials - Phase 2
1. Angel (individual) 12-Jun-2013 $4.25M $4.25M Completed Startup
To view Topical Remedy’s complete valuation and funding history, request access »

Topical Remedy Executive Team (1)

Name Title Board Seat Contact Info
Brad Parrott Founder, Chief Executive Officer & Managing Partner
To view Topical Remedy’s complete executive team members history, request access »

Topical Remedy Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Keiretsu Capital Venture Capital Minority 000 0000 000000 0
Keiretsu Forum Venture Capital Minority 000 0000 000000 0
To view Topical Remedy’s complete investors history, request access »